The PE Ratio as of December 2024 (TTM) for Soleno Therapeutics, Inc. (SLNO) is -16.11

According to Soleno Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -16.11. This represents a change of -12.65% compared to the average of -18.44 of the last 4 quarters.

Soleno Therapeutics, Inc. (SLNO) Historical PE Ratio (quarterly & annually)

How has SLNO PE Ratio performed in the past?

The mean historical PE Ratio of Soleno Therapeutics, Inc. over the last ten years is -3.56. The current -16.11 PE Ratio has changed 45.15% with respect to the historical average. Over the past ten years (40 quarters), SLNO's PE Ratio was at its highest in in the December 2018 quarter at 36.66. The PE Ratio was at its lowest in in the December 2023 quarter at -30.63.

Soleno Therapeutics, Inc. (SLNO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Soleno Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Soleno Therapeutics, Inc. (SLNO) Average PE Ratio

How has SLNO PE Ratio performed in the past?

The current PE Ratio of Soleno Therapeutics, Inc. (SLNO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Soleno Therapeutics, Inc. (SLNO) PE Ratio vs. Peers

How is SLNO’s PE Ratio compared to its peers?

Soleno Therapeutics, Inc.’s PE Ratio is less than Annexon, Inc. (-6.29), less than Icosavax, Inc. (-15.78), less than VectivBio Holding AG (-7.94), less than Bolt Biotherapeutics, Inc. (-0.30), less than Lyra Therapeutics, Inc. (-0.12), less than Pulmatrix, Inc. (-2.18), less than Capricor Therapeutics, Inc. (-13.71), less than Akari Therapeutics, Plc (-0.59), less than Diffusion Pharmaceuticals Inc. (-1.61), less than Onconova Therapeutics, Inc. (-0.09), greater than Catalyst Biosciences, Inc. (-28.92), less than Bio-Path Holdings, Inc. (-0.32), less than Moleculin Biotech, Inc. (-0.21), less than Day One Biopharmaceuticals, Inc. (-14.55), less than Acumen Pharmaceuticals, Inc. (-1.30), less than X4 Pharmaceuticals, Inc. (-6.92), less than Inozyme Pharma, Inc. (-1.97), less than Applied Molecular Transport Inc. (-0.43), less than Aileron Therapeutics, Inc. (-1.39), less than Benitec Biopharma Inc. (-5.74),

Build a custom stock screener for Soleno Therapeutics, Inc. (SLNO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Soleno Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Soleno Therapeutics, Inc. (SLNO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Soleno Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.